| # | Drug | Count |
|---|---|---|
| 0 | RITONAVIR | 233 |
| 1 | RITONAVIR 100 MG | 186 |
| 2 | LAMIVUDINE | 177 |
| 3 | FINGOLIMOD HCL | 163 |
| 4 | LAMIVUDINE ORAL | 161 |
| 5 | ALEMTUZUMAB | 150 |
| 6 | DARUNAVIR | 150 |
| 7 | RITUXIMAB | 119 |
| 8 | ETRAVIRINE | 111 |
| 9 | DARUNAVIR 600 MG | 104 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ACONITUM NAPELLUS, BELLADONNA, CHAMOMILLA | 1 | 0.0400 |
| 1 | ETRAVIRINE | 111 | 0.0250 |
| 2 | DORAVIRINE | 18 | 0.0228 |
| 3 | BENZOIC ACID | 1 | 0.0196 |
| 4 | TECOVIRIMAT MONOHYDRATE | 2 | 0.0192 |
| 5 | DARUNAVIR 600 MG | 104 | 0.0168 |
| 6 | BRINCIDOFOVIR | 2 | 0.0144 |
| 7 | RALTEGRAVIR | 73 | 0.0139 |
| 8 | RITONAVIR 100 MG | 186 | 0.0125 |
| 9 | IBALIZUMAB | 6 | 0.0111 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor [EPC] | 2 | 0.0192 |
| 1 | CD4-directed Blocking Antibody [EPC] | 6 | 0.0111 |
| 2 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 218 | 0.0091 |
| 3 | CD19-directed Cytolytic Antibody [EPC] | 7 | 0.0082 |
| 4 | CD52-directed Cytolytic Antibody [EPC] | 150 | 0.0077 |
| 5 | Protease Inhibitor [EPC] | 302 | 0.0068 |
| 6 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 8 | 0.0063 |
| 7 | Cytochrome P450 3A Inhibitor [EPC] | 343 | 0.0057 |
| 8 | CCR5 Co-receptor Antagonist [EPC] | 13 | 0.0057 |
| 9 | Antileishmanial [EPC] | 2 | 0.0052 |